KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Treasury Shares (2016 - 2026)

Evolent Health has reported Treasury Shares over the past 6 years, most recently at $61.4 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 190.82% year-over-year to $61.4 million; the TTM value through Dec 2025 reached $61.4 million, up 190.82%, while the annual FY2025 figure was $61.4 million, 190.82% up from the prior year.
  • Treasury Shares for Q4 2025 was $6.0 million at Evolent Health, roughly flat from $6.0 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $6.3 million in Q4 2023 and troughed at $1.5 million in Q1 2021.
  • A 5-year average of $2.3 million and a median of $1.5 million in 2021 define the central range for Treasury Shares.
  • Biggest five-year swings in Treasury Shares: changed 0.0% in 2021 and later surged 190.83% in 2025.
  • Year by year, Treasury Shares stood at $21.1 million in 2021, then changed by 0.0% to $21.1 million in 2022, then changed by 0.0% to $21.1 million in 2023, then changed by 0.0% to $21.1 million in 2024, then surged by 190.82% to $61.4 million in 2025.
  • Business Quant data shows Treasury Shares for EVH at $61.4 million in Q4 2025, $61.4 million in Q3 2025, and $21.1 million in Q2 2025.